University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 26 of 26

COMPLETED

Improving Prevention of Heart Disease in Latinos

NCT00101530

COMPLETED Phase 4

A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

NCT00140426

COMPLETED NA

Mechanisms Defending Fat Mass in Humans After Lipectomy

NCT00993213

COMPLETED Phase 1

Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

NCT00255918

TERMINATED NA

Increasing Infant Preventive Health Service Delivery in an Inner City Population

NCT00221507

COMPLETED Phase 2

Skin Cancer Prevention in a Pediatric Population

NCT01464957

COMPLETED NA

Age 12 Follow-up of Early Preventive Intervention (Memphis)

NCT00438165

COMPLETED Phase 2

A Tailored Interactive Website for Promoting Condom Use Among Young Adults

NCT00183638

COMPLETED Phase 2

Exercise for People With Parkinson's Disease

NCT01257945

COMPLETED Phase 2

Phase II Trial for Large ER-Negative Breast Cancers

NCT01869192

COMPLETED NA

Ondansetron Reduce Vomiting Associated With Ketamine PSA

NCT00387556

COMPLETED NA

Exercise and Type 2 Diabetes: Gender and Endothelial Function

NCT01993121

COMPLETED NA

The Care Transitions Intervention

NCT00244491

COMPLETED NA

Intervention Development and Pilot for Foster Care Youth

NCT00809315

COMPLETED Phase 2

Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

NCT01831076

COMPLETED Phase 2

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

NCT00084409

COMPLETED NA

Age 6 Test of Home Visits by Nurses vs Paraprofessionals

NCT00438282

TERMINATED NA

Transplacental Gradients and Transport in Intrauterine Growth Restricted (IUGR) Pregnancies Compared to Normal Pregnancies.

NCT02397291

COMPLETED Phase 3

Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

NCT00006401

COMPLETED Phase 4

Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart

NCT01798992

COMPLETED

Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers

NCT00897364

COMPLETED Phase 1

Gene Therapy in Treating Patients With Metastatic Melanoma

NCT00005943

TERMINATED NA

Airway Secretion Clearance in Cystic Fibrosis

NCT00839644

COMPLETED Phase 2

Irofulven in Treating Patients With Stage IV Melanoma

NCT00005968

COMPLETED Phase 2

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia

NCT00005801

COMPLETED NA

Longitudinal Follow Up of Subjects Enrolled in Randomized Trial of Prenatal and Infancy Home Visitation

NCT00443638

COMPLETED Phase 2

Bryostatin 1 in Treating Patients With Stage IV Breast Cancer

NCT00003205

COMPLETED Phase 3

Embryonic Dopamine Cell Implants for Parkinson's Disease

NCT00038116

COMPLETED Phase 2

Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases

NCT00002655

COMPLETED Phase 1

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

NCT00002572

COMPLETED NA

Randomized Controlled Trial of Chiropractic Manipulation Versus Medical Therapy for Chronic Neck Pain

NCT00429624

COMPLETED Phase 2

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

NCT00103363

COMPLETED Phase 2

13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer

NCT00002586

← Previous Page 26 of 26

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.